Efficacy of Preoperative US Vascular Mapping for Arteriovenous Fistula in Patients with Hemodialysis.
10.3348/jkrs.2007.57.1.81
- Author:
Min Sun LEE
1
;
Ji Young HWANG
;
Byung Chul KANG
;
Seung Yon BAEK
Author Information
1. Department of Radiology, College of Medicine, Ewha Womans University, Korea. bbaek@ewha.ac.kr
- Publication Type:Original Article
- Keywords:
Dialysis;
Fistula, arteriovenous;
Veins, US
- MeSH:
Angioplasty;
Arteriovenous Fistula*;
Dialysis;
Fistula;
Follow-Up Studies;
Humans;
Kidney Failure, Chronic;
Prospective Studies;
Renal Dialysis*;
Transplants
- From:Journal of the Korean Radiological Society
2007;57(1):81-87
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The purpose of this study is to assess the efficacy of preoperative US vascular mapping to predict postoperative patency of the arteriovenous fistula for hemodialysis. MATERIALS AND METHODS: Sixty-six patients who underwent hemodialysis for end-stage renal failure (M: F=34:32, mean age, 58.8 years) were observed prospectively from January 2001 to April 2003. The patients were divided into two groups: the vascular mapping group and the control group. A comparative analysis of the re-operation rate between the two groups was determined by use of the chi-square rest, efficacy of preoperative US vascular mapping according to the type of surgery. A comparative analysis of the secondary patency after percutaneous transluminal angioplasty was determined by the use of Fischer exact test, and a comparative analysis of the diminution of patency during the follow-up periods was determined by the use of the Log-rank test. In the mapping group, the diameters of intraoperatively selected vessels were investigated and compared with the recommended diameter on preoperative US vascular mapping determined statistically by the use of Fisher's exact test. RESULTS: The preoperative US vascular mapping group had relatively lower re-operation rates (11.8%) than the control group (28.1%) (p=0.09). The preventive role of US vascular mapping is more effective in decreasing the re-operation rate for a native arteriorvenous fistula (7.4%) than for a synthetic arteriovenous graft (25.9%) (p=0.06). For patients that had an interventional procedure, the failure rate to obtain a secondary patency was smaller than in the mapping group (33.3%), compared with the control group (46.3%) (p=0.37). Patients in the mapping group had a higher patency than the control group patients for a native arteriovenous fistula (92.0%) and a synthetic arteriovenous graft (71.4%) at one year following surgery (p=0.10, p=0.79). The arteriovenous fistulas in the mapping group had a higher patency for both a native arteriovenous fistula (16.6%) and a synthetic arteriovenous graft (22.2%), which was statistically significant (p=0.01, p=0.03). CONCLUSION: Preoperative US vascular mapping is considered to be a useful technique for the preoperative evaluation of an arteriovenous fistula and to contribute to maintaining its postoperative patency and reducing the rate of repeated surgery.
